Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-19-040458

Options or other derivatives

  • Director acquired 2,285 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lucas Svetlana Director 2019-06-28 Grant or award · Stock Option (right to buy) +2,285 2,285 D
Loading xslF345X03/doc4.xml…